Inflammation and B-cell Lymphoma-2 Associated X Protein Regulate Zinc-Induced Apoptotic Degeneration of Rat Nigrostriatal Dopaminergic Neurons

[1]  M. Herrero,et al.  Inflammation in Parkinson’s disease: role of glucocorticoids , 2015, Front. Neuroanat..

[2]  B. Singh,et al.  Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions , 2015, Molecular Neurobiology.

[3]  R. Fischer,et al.  Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF , 2015, Oxidative medicine and cellular longevity.

[4]  Ashutosh Kumar Singh,et al.  Cypermethrin-Induced Nigrostriatal Dopaminergic Neurodegeneration Alters the Mitochondrial Function:A Proteomics Study , 2014, Molecular Neurobiology.

[5]  N. Chen,et al.  Rotenone Could Activate Microglia Through NFκB Associated Pathway , 2013, Neurochemical Research.

[6]  Y. Nolan,et al.  Parkinson's disease in the nuclear age of neuroinflammation. , 2013, Trends in molecular medicine.

[7]  I. Dimauro,et al.  A simple protocol for the subcellular fractionation of skeletal muscle cells and tissue , 2012, BMC Research Notes.

[8]  David S. Park,et al.  Programmed cell death in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.

[9]  L. Peterson,et al.  Oxidative Stress and Microglial Cells in Parkinson's Disease , 2012, Mediators of inflammation.

[10]  Ashutosh Kumar,et al.  Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: Similarity with paraquat neurotoxicity , 2012, Brain Research.

[11]  Ashutosh Kumar,et al.  Oxidative stress in zinc-induced dopaminergic neurodegeneration: Implications of superoxide dismutase and heme oxygenase-1 , 2011, Free radical research.

[12]  S. Jain,et al.  Melatonin or silymarin reduces maneb‐ and paraquat‐induced Parkinson’s disease phenotype in the mouse , 2010, Journal of pineal research.

[13]  S. Hayley,et al.  Inflammatory Mechanisms of Neurodegeneration in Toxin-Based Models of Parkinson's Disease , 2010, Parkinson's disease.

[14]  Ashutosh Kumar,et al.  Effect of zinc and paraquat co-exposure on neurodegeneration: Modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats , 2010, Free radical research.

[15]  Satya P. Gupta,et al.  Involvement of Nitric Oxide in Maneb- and Paraquat-Induced Parkinson’s Disease Phenotype in Mouse: Is There Any Link with Lipid Peroxidation? , 2010, Neurochemical Research.

[16]  Fred H. Gage,et al.  Mechanisms Underlying Inflammation in Neurodegeneration , 2010, Cell.

[17]  Hai-Jie Yang,et al.  NF-κB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1 , 2010, Neurochemistry International.

[18]  T. Adachi,et al.  Zinc Induces Expression of the BH3-only Protein PUMA Through p53 and ERK Pathways in SH-SY5Y Neuroblastoma Cells , 2009, Neurochemical Research.

[19]  Howard E. Gendelman,et al.  Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.

[20]  B. Ritz,et al.  Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease , 2007, Neurology.

[21]  A. Bartels,et al.  Neuroinflammation in the pathophysiology of Parkinson's disease: Evidence from animal models to human in vivo studies with [11C]‐PK11195 PET , 2007, Movement disorders : official journal of the Movement Disorder Society.

[22]  A. Hofman,et al.  Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease , 2007, Neuroepidemiology.

[23]  G. Deuschl,et al.  Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. , 2007, Current pharmaceutical design.

[24]  I. Ahmad,et al.  Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress. , 2007, Cellular and molecular biology.

[25]  K. Hasan,et al.  Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease , 2006, Clinical Neuroscience Research.

[26]  D. Hoyt,et al.  Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia. , 2005, The Journal of trauma.

[27]  Lin Chen,et al.  Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. , 2005, Genes & development.

[28]  M. Sawada,et al.  Inflammatory process in Parkinson's disease: role for cytokines. , 2005, Current pharmaceutical design.

[29]  P. Nisen,et al.  Protein synthesis-dependent induction of interleukin-1β by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells , 1995, Journal of Clinical Immunology.

[30]  A. Członkowska,et al.  Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease. , 2004, International immunopharmacology.

[31]  Lidong Zhang,et al.  Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines. , 2004, Annals of clinical and laboratory science.

[32]  J. Schulz,et al.  Cellular pathology of Parkinson’s disease: astrocytes, microglia and inflammation , 2004, Cell and Tissue Research.

[33]  J. Feldon,et al.  Genetic ablation of tumor necrosis factor‐alpha (TNF‐α) and pharmacological inhibition of TNF‐synthesis attenuates MPTP toxicity in mouse striatum , 2004, Journal of neurochemistry.

[34]  T. Kuwana,et al.  Bcl-2-family proteins and the role of mitochondria in apoptosis. , 2003, Current opinion in cell biology.

[35]  J. Cleveland,et al.  Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. , 2003, Cancer cell.

[36]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[37]  W. Willett,et al.  Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. , 2003, Archives of neurology.

[38]  G. Deuschl,et al.  Activation of microglia by human neuromelanin is NF‐κB‐dependent and involves p38 mitogen‐activated protein kinase: implications for Parkinson's disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  A. F. Mendes,et al.  Dexamethasone prevents interleukin-1beta-induced nuclear factor-kappaB activation by upregulating IkappaB-alpha synthesis, in lymphoblastic cells. , 2003, Mediators of inflammation.

[40]  A. Carvalho,et al.  Dexamethasone prevents interleukin-1beta-induced nuclear factor-kappaB activation by upregulating IkappaB-alpha synthesis, in lymphoblastic cells. , 2003, Mediators of inflammation.

[41]  J. Cano,et al.  The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh‐TNF‐α, IL‐1β and IFN‐γ , 2002 .

[42]  S. Korsmeyer,et al.  Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Cano,et al.  Histamine Infusion Induces a Selective Dopaminergic Neuronal Death Along with an Inflammatory Reaction in Rat Substantia Nigra , 2000, Journal of neurochemistry.

[44]  A. Malik,et al.  Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. , 1999, Circulation.

[45]  R. Djaldetti,et al.  IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease , 1999 .

[46]  J C Reed,et al.  Bax directly induces release of cytochrome c from isolated mitochondria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Y Agid,et al.  Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Gregory G. Brown,et al.  Occupational exposures to metals as risk factors for Parkinson's disease , 1997, Neurology.

[49]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[50]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[51]  Minoru Harada,et al.  Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients , 1994, Neuroscience Letters.

[52]  P. Riederer,et al.  Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. , 1994, Neuroscience letters.

[53]  C. Choi,et al.  Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. , 1992, The Journal of infectious diseases.

[54]  C D Marsden,et al.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.